首页|阿托伐他汀联合阿司匹林治疗高血压伴动脉粥样硬化的临床疗效分析

阿托伐他汀联合阿司匹林治疗高血压伴动脉粥样硬化的临床疗效分析

扫码查看
目的 研究针对高血压伴动脉粥样硬化患者使用阿托伐他汀联合阿司匹林治疗的临床效果.方法 随机选取2019年1月—2023年6月中国人民解放军联勤保障部队第九〇〇医院收治的80例高血压伴动脉粥样硬化的患者为研究对象,根据不同的治疗方法分为两组,每组40例.两组均使用缬沙坦治疗,对照组在此基础上使用阿司匹林治疗,观察组使用阿托伐他汀联合阿司匹林治疗.比较两组患者治疗前后的血压、血脂水平、斑块面积以及不良反应发生率.结果 治疗前,两组血压水平对比,差异无统计学意义(P>0.05).治疗后,两组的舒张压、收缩压水平均下降,与同组治疗前对比,差异有统计学意义(P均<0.05).治疗后,观察组血脂水平中的三酰甘油(3.27±0.89)mmol/L、总胆固醇(1.08±0.79)mmol/L、低密度脂蛋白胆固醇(2.46±1.37)mmol/L均低于对照组,观察组的高密度脂蛋白胆固醇为(1.95±1.34)mmol/L,高于对照组的(1.38±0.95)mmol/L,差异有统计学意义(t=3.706、3.561、2.773、2.195,P均<0.05).治疗后,观察组斑块面积明显小于对照组,差异有统计学意义(P<0.05).两组不良反应发生率对比,差异无统计学意义(P>0.05).结论 临床中针对高血压伴动脉粥样硬化患者采用阿托伐他汀联合阿司匹林治疗,可以有效降低患者的血脂水平,减少斑块面积,且不会出现更多的不良反应.
Clinical Effect of Atorvastatin Combined with Aspirin in the Treatment of Hypertension with Atherosclerosis
Objective To study the clinical effects of treatment with atorvastatin in combination with aspirin in pa-tients with hypertension with atherosclerosis.Methods Eighty patients with hypertension with atherosclerosis in the 900th Hospital of Chinese People's Liberation Army Joint Logistics Support Forces from January 2019 to June 2023 were selected randomly as the study subjects,and they were divided into two groups according to different treatment methods,with 40 cases in each group.Both groups were treated with valsartan,the control group was treated with aspi-rin on this basis,and the observation group was treated with atorvastatin combined with aspirin.The blood pressure,blood lipid level,plaque area before and after treatment,and the incidence of adverse reactions were compared be-tween the two groups.Results Before treatment,there was no statistically significant difference between the blood pres-sure levels of the two groups(P>0.05).After treatment,the diastolic and systolic blood pressure levels of the two groups decreased,and the differences were statistically significant when compared with the same group before treat-ment(both P<0.05).After treatment,triacylglycerol(3.27±0.89)mmol/L,total cholesterol(1.08±0.79)mmol/L,and low density lipoprotein cholesterol(2.46±1.37)mmol/L in the lipid levels of the observation group were lower than those of the control group,and high density lipoprotein cholesterol of the observation group was(1.95±1.34)mmol/L higher than that of the control group(1.38±0.95)mmol/L,and the differences were statistically significant(t=3.706,3.561,2.773,2.195,all P<0.05).After treatment,the plaque area of the observation group was significantly smaller than that of the control group,and the difference was statistically significant(P<0.05).Comparison of the incidence of adverse reactions between the two groups,and the difference was not statistically significant(P>0.05).Conclusion Clinical treatment with atorvastatin combined with aspirin for patients with hypertension with atherosclerosis can effectively re-duce the patient's lipid level and plaque area without more adverse effects.

HypertensionAtherosclerosisAtorvastatinAspirin

王珠凤

展开 >

中国人民解放军联勤保障部队第九〇〇医院(仓山院区)干部病房,福建福州 350001

高血压 动脉粥样硬化 阿托伐他汀 阿司匹林

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(8)
  • 15